Hepatitis B Virus, Pneumococcal, Diphtheria, and Tetanus Vaccination Responses in Compensated Cirrhosis
Liver International · 2026
DOI: 10.1111/liv.70644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Vincent Haghnejad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hépato-Gastroentérologie, Centre Hospitalier Universitaire Nancy, Nancy, France. Hauptthemen laut MEDLINE: Liver Cirrhosis, Pneumococcal Vaccines, Hepatitis B Vaccines, Diphtheria-Tetanus Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Cirrhosis favours infections that can lead to liver decompensation and death. Some of these infections can be prevented by vaccination. This study aimed to evaluate the immune response after HBV, pneumococcal, diphtheria, and tetanus vaccination in cirrhotic patients.
Methods
Patients with cirrhosis were prescribed 3 doses of hepatitis B vaccine, a tetanus‐diphtheria booster and/or a 13‐valent pneumococcal conjugate vaccine followed by a 23‐valent polysaccharide vaccine. HBs seroconversion was assessed 6 months after the last booster dose. Antibody concentrations for seven pneumococcal serotypes, tetanus and diphtheria were measured by ELISA before (V0) and 4 to 6 months after vaccination (V1).
Results
Of the 125 patients enrolled, 83 were analysed for HBs seroconversion, 119 for pneumococcal vaccine response and 117 for tetanus and diphtheria vaccine response. The anti‐HBs seroconversion rate was 31%. A doubling of the antibody was observed in 19% of cases for tetanus and in 26% of cases for diphtheria. For the pneumococcal vaccine, the global protection (at least 5 antibodies with a concentration ≥ 1.3 mg/L against the 7 serotypes of pneumococcus tested) increased from 39% before vaccination to 80% after vaccination. However, only 48% of patients had a 2‐fold increase in IgG antibody for at least five of the seven serotypes tested.
Conclusion
Our study highlights a weak response to the hepatitis B, tetanus, and diphtheria vaccines and an acceptable immunological response to the pneumococcal vaccine, although lower than in healthy subjects. There is a real need to optimise vaccination in cirrhotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hépato-Gastroentérologie, Centre Hospitalier Universitaire Nancy, Nancy, France.
- INSERM U1256 NGERE, Université De Lorraine, Nancy, France.
- Plateforme D'immunomonitoring Vaccinal, Service D'immunologie Biologique, Hôpital Cochin, AP-HP, Paris, France.
- Laboratoire De Virologie, Centre Hospitalier Universitaire Nancy, Nancy, France.
ORCID-Profile: Hélène Jeulin, Evelyne Schvoerer, Jean Pierre Bronowicki
Zitieren
APA
Haghnejad, V., Lucas, M., Chevrier, L., Jeulin, H., Quilici, I., Daude, S., Bensenane-Oussalah, M., Jacquinot, N., Schvoerer, E., Batteux, F., & Bronowicki, J. P. (2026). Hepatitis B Virus, Pneumococcal, Diphtheria, and Tetanus Vaccination Responses in Compensated Cirrhosis. Liver International. https://doi.org/10.1111/liv.70644
Vancouver
Haghnejad V, Lucas M, Chevrier L, Jeulin H, Quilici I, Daude S, et al. Hepatitis B Virus, Pneumococcal, Diphtheria, and Tetanus Vaccination Responses in Compensated Cirrhosis. Liver International. 2026. doi:10.1111/liv.70644
BibTeX
@article{Haghnejad2026,
author = {Haghnejad, Vincent and Lucas, Mélissa and Chevrier, Lucie and Jeulin, Hélène and Quilici, Isabela and Daude, Sébastien and Bensenane-Oussalah, Mouni and Jacquinot, Nicolas and Schvoerer, Evelyne and Batteux, Frederic and Bronowicki, Jean Pierre},
title = {Hepatitis B Virus, Pneumococcal, Diphtheria, and Tetanus Vaccination Responses in Compensated Cirrhosis},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70644}
}
EUVIMED